The Current Ratio as of December 2025 (TTM) for Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO) is 18.78

According to Anti-Microbial Savior BioteQ Co., Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 18.78. This represents a change of 4.07% compared to the average of 18.04 of the last 4 quarters.

Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO) Historical Current Ratio (quarterly & annually)

How has 6864.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Anti-Microbial Savior BioteQ Co., Ltd over the last ten years is 20.97. The current 18.78 Current Ratio has changed 8.86% with respect to the historical average. Over the past ten years (40 quarters), 6864.TWO's Current Ratio was at its highest in in the June 2024 quarter at 22.45. The Current Ratio was at its lowest in in the December 2023 quarter at 11.94.

Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Anti-Microbial Savior BioteQ Co., Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO) Average Current Ratio

How has 6864.TWO Current Ratio performed in the past?

The current Current Ratio of Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO) Current Ratio vs. Peers

How is 6864.TWO’s Current Ratio compared to its peers?

Anti-Microbial Savior BioteQ Co., Ltd’s Current Ratio is less than TaiRx, Inc. (20.60), greater than Gwo Xi Stem Cell Applied Technology Co. , Ltd (3.10), greater than Taiwan Bio Therapeutics Co., Ltd (8.15), greater than Steminent Biotherapeutics Inc. (6.33), greater than Intech Biopharm Corporation (1.71), greater than HeXun Biosciences Co., Ltd. (8.26), greater than GlycoNex Incorporation (1.67), less than Sinew Pharma Inc. (53.40), greater than Hcmed (11.14), greater than Chunghwa Chemical Synthesis & Biotech Co., Ltd. (2.82),

Build a custom stock screener for Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anti-Microbial Savior BioteQ Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anti-Microbial Savior BioteQ Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.